Master data| INID | Criterion | Field | Content | 
|---|
|  | Type of IP right | SART | Patent | 
|  | Status | ST | Not pending/lapsed | 
| 21 | DE file number | DAKZ | 60 2009 060 529.1 | 
| 96 | EP file number | EAKZ | 18 17 9301.9 | 
| 97 | EP publication number | EPN | 3409274 | 
| 54 | Designation/title | TI | DOSIERSCHEMA FÜR EINEN S1P-REZEPTOR-AGONISTEN | 
| 51 | IPC main class | ICM (ICMV)
 | A61K 31/4245 (2006.01) | 
| 51 | IPC secondary class(es) | ICS (ICSV)
 | A61P 37/00 (2006.01),   A61P 37/06 (2006.01),   A61K 31/135 (2006.01),   A61K 31/138 (2006.01),   A61K 31/661 (2006.01),   A61K 31/137 (2006.01) | 
| 22 | DE application date | DAT | Dec 21, 2009 | 
| 96 | EP application date | EAT | Dec 21, 2009 | 
| 43 | Date of first publication | OT | Dec 5, 2018 | 
|  | Date of publication of grant | PET | Nov 20, 2019 | 
| 71/73 | Applicant/owner | INH | Novartis AG, Basel, CH | 
| 72 | Inventor | IN | Schmouder, Robert, East Hanover, New Jersey 07936, US; Dumortier, Thomas, 4002 Basel, CH; David, Olivier, 4002 Basel, CH; Looby, Michael, 4002 Basel, CH | 
| 74 | Representative | VTR | Hernandez, Yorck, Dipl.-Ing., 82031 Grünwald, DE | 
|  | Address for service |  | HERNANDEZ IP, 82031 Grünwald, DE | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 139672 P
 Dec 22, 2008
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 246715 P
 Sep 29, 2009
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 218530 P
 Jun 19, 2009
 
 | 
|  | Patent division in charge |  | 44 | 
| 21 | File number of protection certificate | ZAKZ | 12 2020 000 074.4 | 
| 97 | EP language of publication | ELANG | EN - Englisch | 
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | 
|  | Published EP/WO documents | EPWOPN | Original document: 
EP000003409274A1 Searchable text: 
EP000003409274A1
 Original document: 
EP000003409274B1
 Searchable text: 
EP000003409274B1
 | 
| 43 | Date of first publication | EVT | Dec 5, 2018 | 
|  | Date of the first transfer into DPMAregister | EREGT | Dec 5, 2018 | 
|  | Date of the (most recent) update in DPMAregister | REGT | Dec 20, 2024 (Show all update days)(Hide all update days)
 Dec 20, 2024Procedures: Opposition procedure, Decision on revocation by EPO has become final, 27.11.2024: changed
Dec 12, 2024Status: changed
Due date: deleted
Procedures: Opposition procedure, Revocation by EPO, 27.11.2024: new
Procedures: Opposition procedure, Decision on revocation by EPO has become final, 27.11.2024: new
Nov 27, 2024Sep 19, 2024St.36: changed (technical change)
Nov 24, 2023; Jul 8, 2022; Nov 19, 2021; Jul 8, 2021; Feb 26, 2021; Jan 19, 2021; Dec 17, 2020; Dec 5, 2020; Dec 4, 2020; Dec 2, 2020; Oct 8, 2020; Sep 3, 2020; Feb 14, 2020; Nov 27, 2019; Nov 26, 2019; Nov 1, 2019; Oct 31, 2019; Aug 23, 2019; May 30, 2019Historical data not available for this/these date(s)
Dec 5, 2018
 Date of the first transfer into DPMAregister
 |